BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23842546)

  • 1. Landscape of the mitochondrial Hsp90 metabolome in tumours.
    Chae YC; Angelin A; Lisanti S; Kossenkov AV; Speicher KD; Wang H; Powers JF; Tischler AS; Pacak K; Fliedner S; Michalek RD; Karoly ED; Wallace DC; Languino LR; Speicher DW; Altieri DC
    Nat Commun; 2013; 4():2139. PubMed ID: 23842546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells.
    Siegelin MD; Dohi T; Raskett CM; Orlowski GM; Powers CM; Gilbert CA; Ross AH; Plescia J; Altieri DC
    J Clin Invest; 2011 Apr; 121(4):1349-60. PubMed ID: 21364280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase.
    Sciacovelli M; Guzzo G; Morello V; Frezza C; Zheng L; Nannini N; Calabrese F; Laudiero G; Esposito F; Landriscina M; Defilippi P; Bernardi P; Rasola A
    Cell Metab; 2013 Jun; 17(6):988-999. PubMed ID: 23747254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 90beta1 is essential for polyunsaturated fatty acid-induced mitochondrial Ca2+ efflux.
    Zhang H; Li ZH; Zhang MQ; Katz MS; Zhang BX
    J Biol Chem; 2008 Mar; 283(12):7580-9. PubMed ID: 18178560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells.
    Caino MC; Chae YC; Vaira V; Ferrero S; Nosotti M; Martin NM; Weeraratna A; O'Connell M; Jernigan D; Fatatis A; Languino LR; Bosari S; Altieri DC
    J Clin Invest; 2013 Jul; 123(7):2907-20. PubMed ID: 23921130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors.
    Zhang G; Frederick DT; Wu L; Wei Z; Krepler C; Srinivasan S; Chae YC; Xu X; Choi H; Dimwamwa E; Ope O; Shannan B; Basu D; Zhang D; Guha M; Xiao M; Randell S; Sproesser K; Xu W; Liu J; Karakousis GC; Schuchter LM; Gangadhar TC; Amaravadi RK; Gu M; Xu C; Ghosh A; Xu W; Tian T; Zhang J; Zha S; Liu Q; Brafford P; Weeraratna A; Davies MA; Wargo JA; Avadhani NG; Lu Y; Mills GB; Altieri DC; Flaherty KT; Herlyn M
    J Clin Invest; 2016 May; 126(5):1834-56. PubMed ID: 27043285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth.
    Lang SA; Moser C; Gaumann A; Klein D; Glockzin G; Popp FC; Dahlke MH; Piso P; Schlitt HJ; Geissler EK; Stoeltzing O
    Clin Cancer Res; 2007 Nov; 13(21):6459-68. PubMed ID: 17975158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis.
    Tretter L; Patocs A; Chinopoulos C
    Biochim Biophys Acta; 2016 Aug; 1857(8):1086-1101. PubMed ID: 26971832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity.
    Zhao X; Sun K; Lan Z; Song W; Cheng L; Chi W; Chen J; Huo Y; Xu L; Liu X; Deng H; Siegenthaler JA; Chen L
    Sci Rep; 2017 Apr; 7():46344. PubMed ID: 28397817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
    Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
    Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the mitochondrial Hsp90 chaperone network: a novel, efficient treatment strategy for cancer?
    Siegelin MD
    Cancer Lett; 2013 Jun; 333(2):133-46. PubMed ID: 23376257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.
    Masgras I; Ciscato F; Brunati AM; Tibaldi E; Indraccolo S; Curtarello M; Chiara F; Cannino G; Papaleo E; Lambrughi M; Guzzo G; Gambalunga A; Pizzi M; Guzzardo V; Rugge M; Vuljan SE; Calabrese F; Bernardi P; Rasola A
    Cell Rep; 2017 Jan; 18(3):659-672. PubMed ID: 28099845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma.
    Zhang Y; Nguyen TTT; Shang E; Mela A; Humala N; Mahajan A; Zhao J; Shu C; Torrini C; Sanchez-Quintero MJ; Kleiner G; Bianchetti E; Westhoff MA; Quinzii CM; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
    Cancer Res; 2020 Jan; 80(1):30-43. PubMed ID: 31694905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDELR2 Promotes Glioblastoma Tumorigenesis Targeted by HIF1a via mTOR Signaling Pathway.
    Liao Z; She C; Ma L; Sun Z; Li P; Zhang X; Wang P; Li W
    Cell Mol Neurobiol; 2019 Nov; 39(8):1207-1215. PubMed ID: 31342232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-MYC inhibition impairs hypoxia response in glioblastoma multiforme.
    Mongiardi MP; Savino M; Falchetti ML; Illi B; Bozzo F; Valle C; Helmer-Citterich M; Ferrè F; Nasi S; Levi A
    Oncotarget; 2016 May; 7(22):33257-71. PubMed ID: 27119353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth.
    Agarwal E; Altman BJ; Seo JH; Ghosh JC; Kossenkov AV; Tang HY; Krishn SR; Languino LR; Gabrilovich DI; Speicher DW; Dang CV; Altieri DC
    J Biol Chem; 2019 Jul; 294(27):10407-10414. PubMed ID: 31097545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy.
    Barliya T; Mandel M; Livnat T; Weinberger D; Lavie G
    PLoS One; 2011; 6(9):e22849. PubMed ID: 21949677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
    Lang SA; Klein D; Moser C; Gaumann A; Glockzin G; Dahlke MH; Dietmaier W; Bolder U; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Ther; 2007 Mar; 6(3):1123-32. PubMed ID: 17363505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells via the ROS/AMPK/mTOR Pathway.
    Tang H; Li J; Liu X; Wang G; Luo M; Deng H
    Sci Rep; 2016 Jun; 6():28388. PubMed ID: 27325206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.